CN107022045A - latex microsphere and preparation method thereof - Google Patents

latex microsphere and preparation method thereof Download PDF

Info

Publication number
CN107022045A
CN107022045A CN201710296866.5A CN201710296866A CN107022045A CN 107022045 A CN107022045 A CN 107022045A CN 201710296866 A CN201710296866 A CN 201710296866A CN 107022045 A CN107022045 A CN 107022045A
Authority
CN
China
Prior art keywords
preparation
phase solution
latex microsphere
latex
carboxylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710296866.5A
Other languages
Chinese (zh)
Other versions
CN107022045B (en
Inventor
钱福卿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fulong Medical Materials Co Ltd (china)
Original Assignee
Fulong Medical Materials Co Ltd (china)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fulong Medical Materials Co Ltd (china) filed Critical Fulong Medical Materials Co Ltd (china)
Priority to CN201710296866.5A priority Critical patent/CN107022045B/en
Publication of CN107022045A publication Critical patent/CN107022045A/en
Application granted granted Critical
Publication of CN107022045B publication Critical patent/CN107022045B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F212/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
    • C08F212/02Monomers containing only one unsaturated aliphatic radical
    • C08F212/04Monomers containing only one unsaturated aliphatic radical containing one ring
    • C08F212/06Hydrocarbons
    • C08F212/08Styrene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/12Polymerisation in non-solvents
    • C08F2/16Aqueous medium
    • C08F2/22Emulsion polymerisation
    • C08F2/24Emulsion polymerisation with the aid of emulsifying agents
    • C08F2/26Emulsion polymerisation with the aid of emulsifying agents anionic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polymerisation Methods In General (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

The invention discloses a kind of latex microsphere, it is prepared from by following parts by weight of component:30 40 parts of styrene, 2.5 4 parts of acrylic acid, 8 12 parts of emulsifying agent, 0.2 0.4 parts of initiator, 1.5 2.5 parts of organic solvent, 10 20 parts of water.Latex microsphere size uniformity height, carboxylated completely, can effectively ensure that and the using effect after antibody coupling in the present invention.

Description

Latex microsphere and preparation method thereof
Technical field
The present invention relates to biomedicine field, more particularly to a kind of latex microsphere and preparation method thereof.
Background technology
Latex microsphere attracts increasing concern in the extensive use of biological, field of medicaments.In the prior art, latex is micro- The size uniformity of ball is poor, and activated carboxylic rate is 80% or so thereon, during with antibody binding, and antibody distribution consistency degree is low, and Skewness, limits sensitivity and causes antibody bioactive to reduce, mutability causes false negative;When by coupling agent with it is anti- Body be coupled when, the amount of antibody being coated with thereon can be caused very high so that coated antibody surface steric hindrance increase and The free degree is low, sensitivity and increase nonspecific reaction that the immune latex microsphere of reduction is determined.
The content of the invention
In order to overcome the deficiencies in the prior art, it is an object of the invention to provide size uniformity height, carboxylated are complete Latex microsphere.
To solve the above problems, the technical solution adopted in the present invention is as follows:
A kind of latex microsphere, is prepared from by following parts by weight of component:
It is preferred that, it is prepared from by following parts by weight of component:
It is preferred that, the emulsifying agent is dodecyl sodium sulfate.
It is preferred that, the initiator is potassium peroxydisulfate or sodium peroxydisulfate.
It is preferred that, the organic solvent is hexadecane.
Present invention additionally comprises a kind of preparation method of latex microsphere, including:
S101. the preparation of aqueous phase solution:By emulsifying agent obtained aqueous phase solution soluble in water;
S102. the preparation of oil-phase solution:Oil-phase solution is constituted after styrene is mixed with organic solvent;
S103. the preparation of colostric fluid and first carboxylated:Aqueous phase solution, oil-phase solution are mixed to prepare under ultrasound condition Colostric fluid, and by colostric fluid, initiator and 60%-70% acrylic acid add container for stirring it is uniform after, under nitrogen protection, 85 10h is reacted at DEG C;
S104. carboxylated again:Residual acrylic acid is added into the solution after reaction 12h, under nitrogen protection, 80 DEG C of reactions 6h, is produced.
Further, in addition to step S105. by emulsion breaking made from S104, centrifuge, collect product and use deionization Water is cleaned, and gained is latex microsphere.
Further, ultrasound condition is that ultrasonic cell disruptor carries out ultrasound in 400W power in the step S103 Emulsification.
Compared with prior art, the beneficial effects of the present invention are:Latex microsphere size uniformity prepared by the present invention reaches More than 98%, and realize the full carboxylated in present latex particulate surface and stably;The preparation method of present latex particulate is simple in the present invention, system Standby cost of material is low, manufacturing cycle section, can be in large-scale application.
Brief description of the drawings
Fig. 1 is the preparation flow figure of present latex particulate in the present invention.
Embodiment
The present invention is described in further detail with reference to the accompanying drawings and detailed description.
The invention discloses a kind of latex microsphere, it is prepared from by following parts by weight of component:30-40 parts of styrene, propylene It is sour 2.5-4 parts, 8-12 parts of emulsifying agent, 0.2-0.4 parts of initiator, 1.5-2.5 parts of organic solvent, 10-20 parts of water.
It is preferred that, it is prepared from by following parts by weight of component:36 parts of styrene, 4 parts of acrylic acid, 10 parts of emulsifying agent triggers 0.3 part of agent, 2 parts of organic solvent, 10 parts of water.
It is preferred that, the emulsifying agent is dodecyl sodium sulfate.The initiator is potassium peroxydisulfate or sodium peroxydisulfate.It is described Organic solvent is hexadecane.
As shown in figure 1, present invention additionally comprises a kind of preparation method of latex microsphere, including:
S101. the preparation of aqueous phase solution:By emulsifying agent obtained aqueous phase solution soluble in water;
S102. the preparation of oil-phase solution:Oil-phase solution is constituted after styrene is mixed with organic solvent;
S103. the preparation of colostric fluid and first carboxylated:Aqueous phase solution, oil-phase solution are mixed to prepare under ultrasound condition Colostric fluid, and by colostric fluid, initiator and 60%-70% acrylic acid add container for stirring it is uniform after, under nitrogen protection, 85 10h is reacted at DEG C;
S104. carboxylated again:Residual acrylic acid is added into the solution after reaction 12h, under nitrogen protection, 80 DEG C of reactions 6h, is produced.
Further, in addition to step S105. by emulsion breaking made from S104, centrifuge, collect product and use deionization Water is cleaned, and gained is latex microsphere.
Further, ultrasound condition is that ultrasonic cell disruptor carries out ultrasound in 400W power in the step S103 Emulsification.
Embodiment 1
Flow prepares latex microsphere in reference picture 1
S101. the preparation of aqueous phase solution:8g dodecyl sodium sulfates are dissolved in 10g water aqueous phase solution is made;
S102. the preparation of oil-phase solution:Oil-phase solution is constituted after 30g styrene is mixed with 1.5g hexadecanes;
S103. the preparation of colostric fluid and first carboxylated:By aqueous phase solution, oil-phase solution in ultrasonic cell disruptor 400W power carries out ultrasonic emulsification and colostric fluid is made, and the acrylic acid of colostric fluid, 0.2g potassium peroxydisulfates and 1.8g is added into appearance After being stirred in device, under nitrogen protection, 10h is reacted at 85 DEG C;
S104. carboxylated again:Residue 1.8g acrylic acid is added into the solution after reaction 12h, under nitrogen protection, 80 DEG C 6h is reacted, is produced.
S105. by emulsion breaking made from S104, centrifugation, collect product and cleaned with deionized water, gained is that latex is micro- Ball.
After testing, the latex microsphere particle diameter of acquisition is between 55-65nm, and its size uniformity reaches more than 98%.Utilize Conductimetric titration method detects that the full carboxylated in present latex particulate surface reaches more than 99.2%, and carboxylated is steady to carboxyl-content Qualitative height, can effectively ensure that and the using effect after antibody coupling.
Embodiment 2
Flow prepares latex microsphere in reference picture 1
S101. the preparation of aqueous phase solution:10 dodecyl sodium sulfates are dissolved in 10g water aqueous phase solution is made;
S102. the preparation of oil-phase solution:Oil-phase solution is constituted after 36g styrene is mixed with 2g hexadecanes;
S103. the preparation of colostric fluid and first carboxylated:By aqueous phase solution, oil-phase solution in ultrasonic cell disruptor 400W power carries out ultrasonic emulsification and colostric fluid is made, and the acrylic acid of colostric fluid, 0.3g potassium peroxydisulfates and 2.4g is added into appearance After being stirred in device, under nitrogen protection, 10h is reacted at 85 DEG C;
S104. carboxylated again:Residue 1.6g acrylic acid is added into the solution after reaction 12h, under nitrogen protection, 80 DEG C 6h is reacted, is produced.
S105. by emulsion breaking made from S104, centrifugation, collect product and cleaned with deionized water, gained is that latex is micro- Ball.
After testing, the latex microsphere particle diameter of acquisition is between 55-65nm, and its size uniformity reaches more than 98.5%.Profit Carboxyl-content is detected with conductance titration method, the full carboxylated in present latex particulate surface reaches more than 99.5%, and carboxylated Stability is high, can effectively ensure that and the using effect after antibody coupling.
Embodiment 3
Flow prepares latex microsphere in reference picture 1
S101. the preparation of aqueous phase solution:12g dodecyl sodium sulfates are dissolved in 20g water aqueous phase solution is made;
S102. the preparation of oil-phase solution:Oil-phase solution is constituted after 40g styrene is mixed with 2.5g hexadecanes;
S103. the preparation of colostric fluid and first carboxylated:By aqueous phase solution, oil-phase solution in ultrasonic cell disruptor 400W power carries out ultrasonic emulsification and colostric fluid is made, and the acrylic acid of colostric fluid, 0.4g potassium peroxydisulfates and 2.8g is added into appearance After being stirred in device, under nitrogen protection, 10h is reacted at 85 DEG C;
S104. carboxylated again:Residue 1.2g acrylic acid is added into the solution after reaction 12h, under nitrogen protection, 80 DEG C 6h is reacted, is produced.
S105. by emulsion breaking made from S104, centrifugation, collect product and cleaned with deionized water, gained is that latex is micro- Ball.
After testing, the latex microsphere particle diameter of acquisition is between 55-65nm, and its size uniformity reaches more than 98.1%.Profit Carboxyl-content is detected with conductance titration method, the full carboxylated in present latex particulate surface reaches more than 99.1%, and carboxylated Stability is high, can effectively ensure that and the using effect after antibody coupling.
Embodiment 4
Flow prepares latex microsphere in reference picture 1
S101. the preparation of aqueous phase solution:10g dodecyl sodium sulfates are dissolved in 15g water aqueous phase solution is made;
S102. the preparation of oil-phase solution:Oil-phase solution is constituted after 36g styrene is mixed with 2.5g hexadecanes;
S103. the preparation of colostric fluid and first carboxylated:By aqueous phase solution, oil-phase solution in ultrasonic cell disruptor 400W power carries out ultrasonic emulsification and colostric fluid is made, and the acrylic acid of colostric fluid, 0.4g potassium peroxydisulfates and 2.8g is added into appearance After being stirred in device, under nitrogen protection, 10h is reacted at 85 DEG C;
S104. carboxylated again:Residue 1.2g acrylic acid is added into the solution after reaction 12h, under nitrogen protection, 80 DEG C 6h is reacted, is produced.
S105. by emulsion breaking made from S104, centrifugation, collect product and cleaned with deionized water, gained is that latex is micro- Ball.
After testing, the latex microsphere particle diameter of acquisition is between 55-65nm, and its size uniformity reaches more than 98.2%.Profit Carboxyl-content is detected with conductance titration method, the full carboxylated in present latex particulate surface reaches more than 99.3%, and carboxylated Stability is high, can effectively ensure that and the using effect after antibody coupling.
It will be apparent to those skilled in the art that technical scheme that can be as described above and design, make other various It is corresponding to change and deformation, and all these change and deformation should all belong to the protection domain of the claims in the present invention Within.

Claims (8)

1. a kind of latex microsphere, it is characterised in that be prepared from by following parts by weight of component:
2. latex microsphere as claimed in claim 1, it is characterised in that be prepared from by following parts by weight of component:
3. latex microsphere as claimed in claim 1, it is characterised in that the emulsifying agent is dodecyl sodium sulfate.
4. latex microsphere as claimed in claim 1, it is characterised in that the initiator is potassium peroxydisulfate or sodium peroxydisulfate.
5. latex microsphere as claimed in claim 1, it is characterised in that the organic solvent is hexadecane.
6. the preparation method of any one of the claim 1-5 latex microspheres, including:
S101. the preparation of aqueous phase solution:By emulsifying agent obtained aqueous phase solution soluble in water;
S102. the preparation of oil-phase solution:Oil-phase solution is constituted after styrene is mixed with organic solvent;
S103. the preparation of colostric fluid and first carboxylated:Aqueous phase solution, oil-phase solution are mixed to prepare colostrum under ultrasound condition Liquid, and by colostric fluid, initiator and 60%-70% acrylic acid add container for stirring it is uniform after, under nitrogen protection, at 85 DEG C React 10h;
S104. carboxylated again:Residual acrylic acid is added into the solution after reaction 12h, under nitrogen protection, 80 DEG C of reaction 6h, Produce.
7. the preparation method of latex microsphere as claimed in claim 6, it is characterised in that also including step S105. by S104 systems Emulsion breaking, centrifugation, collection product and cleaned with deionized water, gained is latex microsphere.
8. the preparation method of latex microsphere as claimed in claim 6, it is characterised in that ultrasound condition is in the step S103 Ultrasonic cell disruptor carries out ultrasonic emulsification in 400W power.
CN201710296866.5A 2017-04-28 2017-04-28 Latex microsphere and preparation method thereof Active CN107022045B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710296866.5A CN107022045B (en) 2017-04-28 2017-04-28 Latex microsphere and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710296866.5A CN107022045B (en) 2017-04-28 2017-04-28 Latex microsphere and preparation method thereof

Publications (2)

Publication Number Publication Date
CN107022045A true CN107022045A (en) 2017-08-08
CN107022045B CN107022045B (en) 2019-07-02

Family

ID=59527598

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710296866.5A Active CN107022045B (en) 2017-04-28 2017-04-28 Latex microsphere and preparation method thereof

Country Status (1)

Country Link
CN (1) CN107022045B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111607103A (en) * 2020-06-30 2020-09-01 福隆医疗器械集团有限公司 Alkyl phosphono modified collagen-based material, preparation method, modified collagen and application
CN111892736A (en) * 2020-08-13 2020-11-06 上海科华生物工程股份有限公司 Polystyrene microsphere for improving sensitivity of latex turbidimetry and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102492075A (en) * 2011-12-08 2012-06-13 天津医科大学 Nanometer carboxylated polystyrene microsphere with spacer arm and preparation method thereof
CN104311715A (en) * 2014-10-25 2015-01-28 陕西玉航电子有限公司 Preparation method of colloidal microspheres
CN104558351A (en) * 2013-10-21 2015-04-29 大连市沙河口区中小微企业服务中心 Method of surface carboxyl modification of nano/submicron particles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102492075A (en) * 2011-12-08 2012-06-13 天津医科大学 Nanometer carboxylated polystyrene microsphere with spacer arm and preparation method thereof
CN104558351A (en) * 2013-10-21 2015-04-29 大连市沙河口区中小微企业服务中心 Method of surface carboxyl modification of nano/submicron particles
CN104311715A (en) * 2014-10-25 2015-01-28 陕西玉航电子有限公司 Preparation method of colloidal microspheres

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李恒涛等: "苯乙烯-丙烯酸共聚纳米微球的制备及表征", 《塑料工业》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111607103A (en) * 2020-06-30 2020-09-01 福隆医疗器械集团有限公司 Alkyl phosphono modified collagen-based material, preparation method, modified collagen and application
CN111607103B (en) * 2020-06-30 2022-05-17 江苏创健医疗科技有限公司 Alkyl phosphono modified collagen-based material, preparation method, modified collagen and application
CN111892736A (en) * 2020-08-13 2020-11-06 上海科华生物工程股份有限公司 Polystyrene microsphere for improving sensitivity of latex turbidimetry and preparation method thereof
CN111892736B (en) * 2020-08-13 2022-08-26 上海科华生物工程股份有限公司 Polystyrene microsphere for improving sensitivity of latex turbidimetry and preparation method thereof

Also Published As

Publication number Publication date
CN107022045B (en) 2019-07-02

Similar Documents

Publication Publication Date Title
CN107022045A (en) latex microsphere and preparation method thereof
Chan et al. The effect of low air-to-liquid mass flow rate ratios on the size, size distribution and shape of calcium alginate particles produced using the atomization method
CN103183832B (en) A kind of preparation method of magnetic cellulose-chitosan composite microsphere
CN103788526B (en) A kind of preparation method carrying silver polymer microballoon
CN104072656A (en) Method for preparing ferroferric oxide-macromolecule magnetic composite microspheres
CN109082267A (en) A method of addition manganese dioxide particle improves n-octadecane/polystyrene phase microcapsules hot property
Hua CFD simulations of the effects of small dispersed bubbles on the rising of a single large bubble in 2D vertical channels
CN104399527B (en) The preparation method of attapulgite clay/polymeric ionic liquid composite catalyst
CN107224945A (en) It is a kind of using phenolic resin be wall material solids as emulsifying agent dicyclopentadiene microcapsule and preparation method
CN204656399U (en) Stagewise is sized mixing pretreatment unit
CN107652414B (en) A kind of single-component water-based epoxy resin of photocuring, waterproof material and preparation method thereof
CN103194181A (en) Method for preparing spherical controlled beta-cyclodextrin/melamine resin-TiO2 nano phase-change energy storage material
CN104211851A (en) Preparation method of monodisperse macromolecule composite magnetic microspheres
CN103354144A (en) Magnetic composite microsphere as well as preparation method and application thereof
CN203778007U (en) Self-equipped stirring and glue-feeding device of coating head
CN103272541B (en) Method for preparing magnetic silicon oxide polymer composite microspheres with asymmetrical structure and surface anisotropic bifunctional groups
CN104448088B (en) Preparation method of temperature-sensitive anisotropic magnetic microcapsule
CN205346926U (en) Catalysis of heterogeneous sweet smell is packed
CN108554393A (en) Polystyrene-based film chitosan copper removal composite material and preparation method
CN104341549B (en) Preparation method for temperature-sensitive aeolotropic magnetic composite microspheres
CN108003372A (en) A kind of core shell structure particle of conducting polymer coated polymer microballoon and preparation method thereof
CN202460622U (en) Emulsification and polymerization reaction device
CN103804699A (en) Cassava starch magnetic microsphere and preparation method thereof
CN106334503A (en) Method for preparing self repair epoxy resin microcapsule
CN104558351A (en) Method of surface carboxyl modification of nano/submicron particles

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: 213000 No. 18 Jincheng Road, Wujin Economic Development Zone, Changzhou City, Jiangsu Province

Applicant after: Fulong Medical Devices Group Co., Ltd.

Address before: 213000 No. 18 Jincheng Road, Wujin Economic Development Zone, Changzhou City, Jiangsu Province

Applicant before: Fulong medical materials Co. Ltd. (China)

GR01 Patent grant
GR01 Patent grant